## **Core Concept**
The question presents a clinical scenario involving a young male with abdominal pain and a heterogeneous necrotizing mass at the left renal hilum on CT scan, along with elevated levels of either alpha-fetoprotein (AFP) or human chorionic gonadotropin (hCG). This combination of findings suggests a diagnosis of a specific type of tumor.
## **Why the Correct Answer is Right**
The key details in this scenario pointing towards the correct diagnosis include the location of the mass (left renal hilum), its characteristics (heterogeneous and necrotizing), and the elevation of tumor markers AFP or hCG. These features are highly suggestive of a **nonseminomatous germ cell tumor (NSGCT)**, specifically **yolk sac tumor** or **choriocarcinoma**, which are known to produce AFP and hCG, respectively. The kidney is an uncommon site for these tumors, but they can occur in the retroperitoneum, which might be confused with a renal origin.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although renal cell carcinoma can present as a mass in the kidney, it is less commonly associated with elevated AFP or hCG levels.
- **Option B:** This option is incorrect because, while seminomas can produce hCG, they are less likely to present with a heterogeneous necrotizing mass and are more commonly associated with testicular cancer.
- **Option D:** This option is incorrect as there's no common tumor marker or clinical presentation that directly links to a typical diagnosis related to the provided choices.
## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that **germ cell tumors can occur in extragonadal sites**, including the retroperitoneum, and can present with elevated tumor markers (AFP for yolk sac tumors and NSGCT, and hCG for choriocarcinoma and some seminomas). These tumors are highly aggressive and require prompt treatment.
## **Correct Answer:** .
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.